Hypoglykæmi Patienter, der får rosiglitazon i kombination med et sulfonylurinstof eller insulin, kan have risiko for dosis- relateret hypoglykæmi.
Hypoglycaemia Patients receiving rosiglitazone in combination therapy with a sulphonylurea or with insulin, may be at risk for dose-related hypoglycaemia.